Financhill
Sell
44

ARCT Quote, Financials, Valuation and Earnings

Last price:
$20.81
Seasonality move :
3.48%
Day range:
$17.85 - $19.16
52-week range:
$14.30 - $45.00
Dividend yield:
0%
P/E ratio:
8.50x
P/S ratio:
3.61x
P/B ratio:
1.97x
Volume:
895.9K
Avg. volume:
396K
1-year change:
-38.94%
Market cap:
$516.6M
Revenue:
$157.7M
EPS (TTM):
-$2.22

Earnings Data

Next earnings date for ARCT
Mar 07
2025
Most recent earnings per share
-$0.26
Beat by $0.76
(Nov 7/2024)
Consensus Estimate
-$1.02
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $53M -- -- -$0.27 --
03/07/2025 Q4 $45.9M -- -- -$0.51 --
11/07/2024 Q3 $36.6M $38.8M -$0.26 -$1.02 $0.76
08/05/2024 Q2 $22.2M $46M -$0.64 -$1.57 $0.93
05/08/2024 Q1 $17.7M $32.6M -$1.00 -$1.14 $0.14
03/07/2024 Q4 $37.9M $25.1M -$0.32 -$1.05 $0.73
11/14/2023 Q3 -- -- -$0.61 -$1.63 $1.02
08/07/2023 Q2 -- -- -$1.98 -$0.42 -$1.56
05/09/2023 Q1 -- -- $1.87 $0.65 $1.22
03/28/2023 Q4 -- -- $4.43 $1.23 $3.20
11/09/2022 Q3 -- -- -$1.33 -$1.81 $0.48
08/09/2022 Q2 -- -- -$0.82 -$1.88 $1.06
05/09/2022 Q1 -- -- -$1.94 -$1.40 -$0.54
02/28/2022 Q4 -- -- -$1.47 -$1.69 $0.22
11/08/2021 Q3 -- -- -$2.05 -$1.52 -$0.53
08/10/2021 Q2 -- -- -$2.07 -$2.25 $0.18
05/10/2021 Q1 -- -- -$2.15 -$1.23 -$0.92
03/01/2021 Q4 -- -- -$1.36 -$0.86 -$0.50
11/09/2020 Q3 -- -- -$0.92 -$0.49 -$0.43
08/10/2020 Q2 -- -- -$0.55 -- --
05/07/2020 Q1 -- -- -$0.67 -$0.72 $0.05
03/11/2020 Q4 -- -- -$0.76 -$0.63 -$0.13
11/07/2019 Q3 -- -- -$0.56 -$0.65 $0.09
08/15/2019 Q2 -- -- -- -$0.67 --
05/13/2019 Q1 -- -- -- -$0.60 --
03/18/2019 Q4 -- -- -- -$0.52 --
10/01/2018 Q3 -- -- -- -$0.35 --
06/30/2018 Q2 -- -- -- -$0.34 --
05/14/2018 Q1 -- -- -- -$0.33 --
12/31/2017 Q4 -- -- -- -- --
11/09/2017 Q3 -- -- -- -- --
08/11/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
02/15/2017 Q4 -- -- -- -- --
11/15/2016 Q3 -- -- -- -- --
08/30/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --

Arcturus Therapeutics Holdings Earnings Questions

  • How Much did Arcturus Therapeutics Holdings Generate in Revenue Last Quarter?

    Arcturus Therapeutics Holdings reported $38.8M worth of top line sales in its most recent quarter.

  • Did Arcturus Therapeutics Holdings Beat Earnings Last Quarter?

    Arcturus Therapeutics Holdings announced earnings per share of -$0.26 which represents a beat of analyst forecast a -$1.02 per share.

  • Is Arcturus Therapeutics Holdings Profitable?

    Arcturus Therapeutics Holdings reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Arcturus Therapeutics Holdings EPS Next Year?

    Arcturus Therapeutics Holdings's earnings are forecast to decrease from -$1.12 per share to -$2.39 per share next year representing a decrease of -113.63%.

  • When is Arcturus Therapeutics Holdings's Earnings Date?

    Arcturus Therapeutics Holdings's next earnings date is March 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 125x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
NARI alert for Jan 7

Inari Medical [NARI] is up 22.25% over the past day.

Buy
70
PDEX alert for Jan 7

Pro-Dex [PDEX] is down 10.89% over the past day.

Buy
52
ALCO alert for Jan 7

Alico [ALCO] is down 3.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock